I.CERAM SA (FR:ALICR) has released an update.
I.Ceram SA, a leader in orthopedic and ceramic implants, obtains an extension from the Limoges Commercial Court to defer the General Meeting for approving its 2023 accounts until September 30, 2024. The company, established in 2005, is accelerating its growth in the bioceramics field, supported by its advanced technology and extensive industry experience.
For further insights into FR:ALICR stock, check out TipRanks’ Stock Analysis page.